Affordable Access

Publisher Website

Paths to stemness: building the ultimate antitumour T cell.

Authors
Type
Published Article
Journal
Nat Rev Cancer
1474-175X
Publication Date
Volume
12
Issue
10
Pages
671–684
Identifiers
DOI: 10.1038/nrc3322
PMID: 22996603
Source
Medline

Abstract

Stem cells are defined by the ability to self-renew and to generate differentiated progeny, qualities that are maintained by evolutionarily conserved pathways that can lead to cancer when deregulated. There is now evidence that these stem cell-like attributes and signalling pathways are also shared among subsets of mature memory T lymphocytes. We discuss how using stem cell-like T cells can overcome the limitations of current adoptive T cell therapies, including inefficient T cell engraftment, persistence and ability to mediate prolonged immune attack. Conferring stemness to antitumour T cells might unleash the full potential of cellular therapies.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments